Piper Sandler Maintains Neutral on Bausch Health Companies, Lowers Price Target to $6

Piper Sandler analyst David Amsellem maintains Bausch Health Companies (NYSE:BHC) with a Neutral and lowers the price target from $7 to $6.

Piper Sandler analyst David Amsellem maintains Bausch Health Companies (NYSE:BHC) with a Neutral and lowers the price target from $7 to $6.

Total
0
Shares
Related Posts